ARCHIVES

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991

ACS Funds $54 Million in Grants

June 28, 2002

Hopkins Challenges Litton For Research Contract At FCRF

April 16, 1982